CN105816810A - Hemorrhoids cream for acupoints - Google Patents
Hemorrhoids cream for acupoints Download PDFInfo
- Publication number
- CN105816810A CN105816810A CN201610280299.XA CN201610280299A CN105816810A CN 105816810 A CN105816810 A CN 105816810A CN 201610280299 A CN201610280299 A CN 201610280299A CN 105816810 A CN105816810 A CN 105816810A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- acupuncture point
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014617 hemorrhoid Diseases 0.000 title abstract description 24
- 239000006071 cream Substances 0.000 title abstract description 6
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 19
- 238000001467 acupuncture Methods 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 7
- 239000002671 adjuvant Substances 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 241000825107 Hierochloe Species 0.000 claims 1
- 235000015466 Hierochloe odorata Nutrition 0.000 claims 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical group [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 13
- 230000036407 pain Effects 0.000 abstract description 13
- 206010030113 Oedema Diseases 0.000 abstract description 7
- 208000032843 Hemorrhage Diseases 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 208000033809 Suppuration Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 238000005469 granulation Methods 0.000 abstract description 2
- 230000003179 granulation Effects 0.000 abstract description 2
- 230000001338 necrotic effect Effects 0.000 abstract description 2
- 230000000740 bleeding effect Effects 0.000 abstract 2
- 206010049555 Anal haemorrhage Diseases 0.000 abstract 1
- 206010065360 Anal prolapse Diseases 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 208000034158 bleeding Diseases 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 9
- 210000000436 anus Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 5
- 230000008034 disappearance Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 201000007772 internal hemorrhoid Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010038084 Rectocele Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000002255 anal canal Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 201000000195 skin tag Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses hemorrhoids cream for acupoints, and particularly relates to a medical patch. The hemorrhoids cream is prepared from, by weight, 1-2 parts of cortex magnoliae officinalis, 1-2 parts of licorice root, 1-2 parts of rhizoma arisaematis, 1-2 parts of rhizoma atractylodis, 2-3 parts of dried tangerine peel, 2-3 parts of radix angelicae, 4-5 parts of Radix et Rhizoma Rhei, 4-5 parts of rhizoma curcumae longae, 4-5 parts of cortex phellodendri and 7-8 parts of radix trichosanthis. The radix trichosanthis has functions of activating blood circulation to remove stasis, stopping pain and bleeding, achieving convergence and eliminating dampness, removing necrotic tissue and promoting granulation and the like, and the rate of curing the anal prolapse and bleeding, edema, suppuration and pains caused by various types of hemorrhoids through acupoints and meridians reaches 100%.
Description
Technical field
The present invention relates to medical tape preparation, specifically a kind of acupuncture point ZHICHUANG GAO.
Background technology
Hemorrhoid are due to anorectal region bottom because mucosa lining moves down and poor blood circulation, blood
The soft vein that backflow obstacle causes the expansion of vein flexing to be formed is rolled into a ball or anal canal week skin tag hypertrophy.Hemorrhoid
Skin ulcer is a kind of commonly encountered diseases, frequently-occurring disease, and the sickness rate of hemorrhoid accounts for the 87.5% of anal and intestinal disease sickness rate
Left and right.Hemorrhoid include internal hemorrhoid, external hemorrhoid, mixed hemorrhoid, the cardinal symptom of hemorrhoid:
1, occur that Silent Neuritis is hemorrhage during stool: may occur in which band blood after an action of the bowels, bleed or penetrate blood.
It is often intermittent.The hemorrhage anemia that with the passing of time can cause, occur dizzy, breathe hard, weak, notably
The symptoms such as hemorrhagic shock can occur.
2, hemorrhoid block abjection: slight internal hemorrhoid anus is deviate from without swollen thing, moderate hemorrhoid can be deviate from after an action of the bowels
Anus but can reply voluntarily, severe hemorrhoids or the person that the has incarceration thing that swells after an action of the bowels can not return and receives in anus.
3, pain: when blood examination external hemorrhoid or hemorrhoid inflammation, abjection incarceration, anus can cause local
Swell and ache, be on tenterhooks.
4, moist, pruritus: crissum trace can be caused to itch when internal hemorrhoid, external hemorrhoid accompanying infection erosion,
Moist uncomfortable.
The medicine treating hemorrhoid in the market is mainly medicine for external use such as MAYINGLONGZHICHUANGGAO, Fel Ursi
Hemorrhoid spirit cream etc., oral drugs such as hemorrhoid spirit sheet, Zhixue capsule, disappear de-only sheet etc., has more pair
Effect, the usage of some patch is that route of administration is extremely inconvenient directly against spreading on anus local.
On market, only with " anus is safe " containing western medicine composition, patch is in clinical practice, and this plaster is in umbilical part
Treatment hemorrhoid, Department of Pharmacy's systemic Absorption, but this medicine contains the one-tenth making people produce dependency side effect
Part papaverin hydrochloride.
Summary of the invention
The technical problem to be solved is to provide by one dredging acupuncture point meridian respectively
The rectocele hemorrhage that the hemorrhoid of type are caused, edema, suppurate, the acupuncture point hemorrhoid that pain is cured
Skin ulcer cream.
For solving above-mentioned technical problem, the technical solution used in the present invention is:
A kind of acupuncture point ZHICHUANG GAO, it is characterised in that: include the component of following parts by weight: purple
Cortex Magnoliae Officinalis 1-2 part, Radix Glycyrrhizae 1-2 part, Rhizoma Arisaematis 1-2 part, Rhizoma Atractylodis 1-2 part, Pericarpium Citri Reticulatae 2-3 part,
Radix Angelicae Dahuricae 2-3 part, Radix Et Rhizoma Rhei 4-5 part, Rhizoma Curcumae Longae 4-5 part, Cortex Phellodendri 4-5 part, Radix Trichosanthis 7-8 part.
Further technical scheme is, also includes that appropriate adjuvant, described adjuvant are Mel.
Further technical scheme is, described a kind of acupuncture point ZHICHUANG GAO includes following weight
The component of number: purple Cortex Magnoliae Officinalis 1 part, 1 part of Radix Glycyrrhizae, Rhizoma Arisaematis 1 part, Rhizoma Atractylodis 1 part, Pericarpium Citri Reticulatae
2 parts, the Radix Angelicae Dahuricae 2 parts, Radix Et Rhizoma Rhei 4 parts, 4 parts of Rhizoma Curcumae Longae, Cortex Phellodendri 4 parts, Radix Trichosanthis 7 parts.
Further technical scheme is, described a kind of acupuncture point ZHICHUANG GAO includes following weight
The component of number: purple Cortex Magnoliae Officinalis 2 parts, 2 parts of Radix Glycyrrhizae, Rhizoma Arisaematis 2 parts, Rhizoma Atractylodis 2 parts, Pericarpium Citri Reticulatae
3 parts, the Radix Angelicae Dahuricae 3 parts, Radix Et Rhizoma Rhei 5 parts, 5 parts of Rhizoma Curcumae Longae, Cortex Phellodendri 5 parts, Radix Trichosanthis 8 parts.
Further technical scheme is, described a kind of acupuncture point ZHICHUANG GAO includes following weight
The component of number: purple Cortex Magnoliae Officinalis 1.5 parts, 1.5 parts of Radix Glycyrrhizae, Rhizoma Arisaematis 1.5 parts, Rhizoma Atractylodis 1.5
Part, Pericarpium Citri Reticulatae 2.5 parts, the Radix Angelicae Dahuricae 2.5 parts, Radix Et Rhizoma Rhei 4.5 parts, 4.5 parts of Rhizoma Curcumae Longae, Cortex Phellodendri 4.5
Part, Radix Trichosanthis 7.8 parts.
Further technical scheme is, described a kind of acupuncture point ZHICHUANG GAO includes following weight
The component of number: purple Cortex Magnoliae Officinalis 1 part, 2 parts of Radix Glycyrrhizae, Rhizoma Arisaematis 2 parts, Rhizoma Atractylodis 1 part, Pericarpium Citri Reticulatae
2.5 parts, the Radix Angelicae Dahuricae 2.5 parts, Radix Et Rhizoma Rhei 5 parts, 4 parts of Rhizoma Curcumae Longae, Cortex Phellodendri 5 parts, Radix Trichosanthis 8 parts,
Mel 100 parts.
Further technical scheme also resides in, and its preparation method is: by the purple of above-mentioned parts by weight
Cortex Magnoliae Officinalis, Radix Glycyrrhizae, Rhizoma Arisaematis, Rhizoma Atractylodis, Pericarpium Citri Reticulatae, the Radix Angelicae Dahuricae, Radix Et Rhizoma Rhei, Rhizoma Curcumae Longae, Cortex Phellodendri, variola
Powder is ground into fine powder and mixs homogeneously with the Mel of above-mentioned parts by weight and be modulated into ointment.
Use and have the beneficial effects that produced by technique scheme: the present invention has invigorating blood circulation
The stasis of blood, the effects such as analgesic therapy is stopped blooding, and restrains damp eliminating, removing the necrotic tissue and promoting granulation, by acupuncture point meridian to various types of
The rectocele hemorrhage that the hemorrhoid of type are caused, edema, suppurate, pain cure rate reaches 100%.
Using the beginning pain relieving that will take effect for about five hours, hemostasis, detumescence, 12 hours left
The right side will reduce in blood stasis softening, eliminates edema, convergence, controls symptom extensive about twenty four hours
Multiple pain disappearance edema disappearance blood stasis diminishes, and subsides a swelling to suppurate by the effect of acupuncture point and meridians and recovers
Normally.
Detailed description of the invention
Below the technical scheme in the embodiment of the present invention is clearly and completely described, it is clear that
Described embodiment is only a part of embodiment of the present invention rather than whole enforcement
Example.Based on the embodiment in the present invention, those of ordinary skill in the art are not making creativeness
The every other embodiment obtained under work premise, broadly falls into the scope of protection of the invention.
Elaborate a lot of detail in the following description so that fully understanding the present invention, but
It is that the present invention can also use other to be different from alternate manner described here to implement, this area
Technical staff can be similar popularization, the therefore present invention in the case of intension of the present invention
Do not limited by following public specific embodiment.
The present invention includes the component of following parts by weight: purple Cortex Magnoliae Officinalis 1-2 part, Radix Glycyrrhizae 1-2 part,
Rhizoma Arisaematis 1-2 part, Rhizoma Atractylodis 1-2 part, Pericarpium Citri Reticulatae 2-3 part, Radix Angelicae Dahuricae 2-3 part, Radix Et Rhizoma Rhei 4-5 part,
Rhizoma Curcumae Longae 4-5 part, Cortex Phellodendri 4-5 part, Radix Trichosanthis 7-8 part.
Also include that appropriate adjuvant, described adjuvant are Mel.
By the purple Cortex Magnoliae Officinalis of above-mentioned parts by weight, Radix Glycyrrhizae, Rhizoma Arisaematis, Rhizoma Atractylodis, Pericarpium Citri Reticulatae, the Radix Angelicae Dahuricae,
Radix Et Rhizoma Rhei, Rhizoma Curcumae Longae, Cortex Phellodendri, Radix Trichosanthis be ground into fine powder mix homogeneously with appropriate Mel be modulated into soft
Cream.
Embodiment one
By the purple Cortex Magnoliae Officinalis 1 part of above-mentioned parts by weight, 1 part of Radix Glycyrrhizae, Rhizoma Arisaematis 1 part, Rhizoma Atractylodis 1
Part, Pericarpium Citri Reticulatae 2 parts, the Radix Angelicae Dahuricae 2 parts, Radix Et Rhizoma Rhei 4 parts, 4 parts of Rhizoma Curcumae Longae, Cortex Phellodendri 4 parts, Radix Trichosanthis
7 parts are ground into fine powder, spread on waist at SHENYU acupoint,
Embodiment two
By the purple Cortex Magnoliae Officinalis 2 parts of above-mentioned parts by weight, 2 parts of Radix Glycyrrhizae, Rhizoma Arisaematis 2 parts, Rhizoma Atractylodis 2
Part, Pericarpium Citri Reticulatae 3 parts, the Radix Angelicae Dahuricae 3 parts, Radix Et Rhizoma Rhei 5 parts, 5 parts of Rhizoma Curcumae Longae, Cortex Phellodendri 5 parts, Radix Trichosanthis
8 parts are ground into fine powder, spread on waist at SHENYU acupoint.
Embodiment three
By the purple Cortex Magnoliae Officinalis 1.5 parts of above-mentioned parts by weight, 1.5 parts of Radix Glycyrrhizae, Rhizoma Arisaematis 1.5 parts,
Rhizoma Atractylodis 1.5 parts, Pericarpium Citri Reticulatae 2.5 parts, the Radix Angelicae Dahuricae 2.5 parts, Radix Et Rhizoma Rhei 4.5 parts, 4.5 parts of Rhizoma Curcumae Longae,
Cortex Phellodendri 4.5 parts, Radix Trichosanthis 7.8 parts is ground into fine powder, spreads on waist at SHENYU acupoint.
Embodiment four
By the purple Cortex Magnoliae Officinalis 1 part of above-mentioned parts by weight, 2 parts of Radix Glycyrrhizae, Rhizoma Arisaematis 2 parts, Rhizoma Atractylodis 1
Part, Pericarpium Citri Reticulatae 2.5 parts, the Radix Angelicae Dahuricae 2.5 parts, Radix Et Rhizoma Rhei 5 parts, 4 parts of Rhizoma Curcumae Longae, Cortex Phellodendri 5 parts, sky
8 parts of Mel with 100 parts of pollen are mixed homogeneously and are modulated into ointment.
Equally, above-described embodiment 1-3 also can reconcile into ointment with Mel and use, or uses egg
It is in harmonious proportion clearly use, all can have effect.
Cortex Phellodendri heat clearing and damp drying, removing toxic substances and promoting subsidence of swelling, Rhizoma Curcumae Longae circulation of qi promoting removing blood stasis with potent drugs, pain relieving, Radix Angelicae Dahuricae wet dissipation pain relieving,
Detumescence and apocenosis, Rhizoma Atractylodis dampness is warded off dirty, and Cortex Magnoliae Officinalis is the aromatic damp resolving drug in Chinese medicine.Efficacy of drugs:
Dampness is except full, therapeutic method to keep the adverse QI flowing downwards removing food stagnancy.Pericarpium Citri Reticulatae acrid in the mouth, hardship, warm in nature, there is circulation of qi promoting spleen invigorating, dampness
Effect of expectorant.Radix Et Rhizoma Rhei can reach purging heat and dredging bowels, eliminating blood stasis and inducing menstruation, removing pathogenic heat from blood and toxic substance from the body.For blood stasis warp
Closing, jaundice due to damp-heat, heat in blood tells nosebleed, excess-heat constipation, stagnant stomachache, carbuncle furuncle, Rhizoma Arisaematis
Drying dampness to eliminate phlegm, dispersing swelling and dissipating binds, and have the hoop collection effect of crowding around, Radix Trichosanthis evacuation of pus is subsided a swelling, and Radix Glycyrrhizae is delayed
Anxious pain relieving, removing toxic substances, and can be in harmonious proportion medicine.Full side heat-clearing and toxic substances removing, drying dampness to eliminate phlegm, reducing swelling and alleviating pain,
The effect crowded around.
The present invention is using the beginning pain relieving that will take effect for about five hours, hemostasis, detumescence, and 12
Blood stasis softening will reduce about hour, eliminate edema, convergence, control about twenty four hours
Glucose recovery pain disappearance edema disappearance blood stasis diminishes, by the effect detumescenceization of acupuncture point and meridians
Pus recovers normal.
Claims (7)
1. an acupuncture point ZHICHUANG GAO, it is characterised in that: include the component of following parts by weight:
Purple Cortex Magnoliae Officinalis 1-2 part, Radix Glycyrrhizae 1-2 part, Rhizoma Arisaematis 1-2 part, Rhizoma Atractylodis 1-2 part, Pericarpium Citri Reticulatae 2-3
Part, Radix Angelicae Dahuricae 2-3 part, Radix Et Rhizoma Rhei 4-5 part, Rhizoma Curcumae Longae 4-5 part, Cortex Phellodendri 4-5 part, Radix Trichosanthis
7-8 part.
A kind of acupuncture point the most according to claim 1 ZHICHUANG GAO, it is characterised in that: also
Including appropriate adjuvant, described adjuvant is Mel.
A kind of acupuncture point the most according to claim 1 ZHICHUANG GAO, it is characterised in that: institute
A kind of acupuncture point ZHICHUANG GAO stated includes the component of following parts by weight: purple Cortex Magnoliae Officinalis 1 part, Radix Glycyrrhizae
1 part, Rhizoma Arisaematis 1 part, Rhizoma Atractylodis 1 part, Pericarpium Citri Reticulatae 2 parts, the Radix Angelicae Dahuricae 2 parts, Radix Et Rhizoma Rhei 4 parts, Rhizoma Zingiberis Recens
Yellow 4 parts, Cortex Phellodendri 4 parts, Radix Trichosanthis 7 parts.
A kind of acupuncture point the most according to claim 1 ZHICHUANG GAO, it is characterised in that: institute
A kind of acupuncture point ZHICHUANG GAO stated includes the component of following parts by weight: purple Cortex Magnoliae Officinalis 2 parts, Radix Glycyrrhizae
2 parts, Rhizoma Arisaematis 2 parts, Rhizoma Atractylodis 2 parts, Pericarpium Citri Reticulatae 3 parts, the Radix Angelicae Dahuricae 3 parts, Radix Et Rhizoma Rhei 5 parts, Rhizoma Zingiberis Recens
Yellow 5 parts, Cortex Phellodendri 5 parts, Radix Trichosanthis 8 parts.
A kind of acupuncture point the most according to claim 1 ZHICHUANG GAO, it is characterised in that: institute
A kind of acupuncture point ZHICHUANG GAO stated includes the component of following parts by weight: purple Cortex Magnoliae Officinalis 1.5 parts, sweet
Grass 1.5 parts, Rhizoma Arisaematis 1.5 parts, Rhizoma Atractylodis 1.5 parts, Pericarpium Citri Reticulatae 2.5 parts, the Radix Angelicae Dahuricae 2.5 parts,
Radix Et Rhizoma Rhei 4.5 parts, 4.5 parts of Rhizoma Curcumae Longae, Cortex Phellodendri 4.5 parts, Radix Trichosanthis 7.8 parts.
A kind of acupuncture point the most according to claim 2 ZHICHUANG GAO, it is characterised in that: institute
A kind of acupuncture point ZHICHUANG GAO stated includes the component of following parts by weight: purple Cortex Magnoliae Officinalis 1 part, Radix Glycyrrhizae
2 parts, Rhizoma Arisaematis 2 parts, Rhizoma Atractylodis 1 part, Pericarpium Citri Reticulatae 2.5 parts, the Radix Angelicae Dahuricae 2.5 parts, Radix Et Rhizoma Rhei 5 parts,
4 parts of Rhizoma Curcumae Longae, Cortex Phellodendri 5 parts, Radix Trichosanthis 8 parts, Mel 100 parts.
7. according to a kind of acupuncture point ZHICHUANG GAO described in claim 1-6 any one claim
Preparation method, it is characterised in that: by the purple Cortex Magnoliae Officinalis of above-mentioned parts by weight, Radix Glycyrrhizae, Rhizoma Arisaematis,
Rhizoma Atractylodis, Pericarpium Citri Reticulatae, the Radix Angelicae Dahuricae, Radix Et Rhizoma Rhei, Rhizoma Curcumae Longae, Cortex Phellodendri, Radix Trichosanthis are ground into fine powder and above-mentioned weight
The Mel mix homogeneously of number is modulated into ointment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610280299.XA CN105816810A (en) | 2016-04-29 | 2016-04-29 | Hemorrhoids cream for acupoints |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610280299.XA CN105816810A (en) | 2016-04-29 | 2016-04-29 | Hemorrhoids cream for acupoints |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105816810A true CN105816810A (en) | 2016-08-03 |
Family
ID=56528024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610280299.XA Pending CN105816810A (en) | 2016-04-29 | 2016-04-29 | Hemorrhoids cream for acupoints |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105816810A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1365781A (en) * | 2001-01-19 | 2002-08-28 | 杨孟君 | Nano medicine 'Ruyi Jinhuang' and its preparing process |
-
2016
- 2016-04-29 CN CN201610280299.XA patent/CN105816810A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1365781A (en) * | 2001-01-19 | 2002-08-28 | 杨孟君 | Nano medicine 'Ruyi Jinhuang' and its preparing process |
Non-Patent Citations (2)
| Title |
|---|
| 李理等: "如懿金黄膏治疗炎性外痔的临床观察", 《中医药导报》 * |
| 杨克新: "《人体经络穴位使用全书》", 30 April 2013, 天津科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240102982A (en) | Traditional Chinese herbal medicine for the treatment of hives, eczema, allergies/kinetic reactive constitution | |
| CN102309723B (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN108186839A (en) | A kind of hot compress agent for treating pelvic infecton and its hot compress method | |
| CN101670044A (en) | Medicine for curing gestational chloasma and preparation method thereof | |
| CN104383445A (en) | Traumatic injury analgesic | |
| CN103908600B (en) | The external used medicine for the treatment of rheumatoid arthritis damp-heat arthralgia resistance card and preparation method | |
| CN101391053B (en) | Traditional Chinese medicine composition for treating hemorrhoid | |
| CN103127465B (en) | Chinese medicament for treating mammary gland hyperplasia | |
| CN106177639A (en) | One treats psoriatic Chinese medicine composition and preparation method thereof | |
| CN105816810A (en) | Hemorrhoids cream for acupoints | |
| CN101129678A (en) | Externally used formulated product for treating empyrosis and method of preparing the same | |
| CN102824608A (en) | Externally used Chinese herba preparation for treating peripheral vascular disease | |
| CN103961656B (en) | A kind of traditional Chinese medicine for treating chronic venous insufficiency of lower extremities | |
| CN102895600A (en) | Pharmaceutical composition for treatment of varicosity and preparation method thereof | |
| CN102579623A (en) | Preparation method of Chinese lotion for treating traumatic type ecthyma | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN106177548A (en) | A kind of Chinese medicine treating otitis externa and preparation method thereof | |
| CN105535209A (en) | External washing traditional Chinese medicine composition for treating haemorrhoids | |
| CN105998983A (en) | Traditional Chinese medicinal composition for treating gynecological inflammation | |
| CN105343247A (en) | Traditional Chinese medicinal composition having function of relieving pain and preparation method of traditional Chinese medicinal composition | |
| CN106075268A (en) | A kind of Chinese medicine composition treating scabies | |
| CN105770626A (en) | Traditional Chinese medicine composition for treating epifolliculitis | |
| CN105327290A (en) | Traditional Chinese medicine for external use for treating diabetic gangrene and preparation method thereof | |
| CN103127352B (en) | Chinese medicine composition for treating blood stasis type irregular menstruation | |
| CN104758830A (en) | Traditional Chinese medicine composition for treating bone disease and skin injury and preparation method of traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160803 |